---
_schema: default
id: 182602
date: 2025-02-20
title: >-
    How do non-cancer and cancer risk assessments differ in chemical risk assessment?
article_title: >-
    How do non-cancer and cancer risk assessments differ in chemical risk assessment?
date_format: MMM DD, YYYY
post_on_text: Posted on
seo:
  title: QuickTakes | Health Studies
  page_description: >-
    This content discusses the differences between non-cancer and cancer risk assessments in chemical risk assessment, detailing their methodologies, focus on health effects, complexity, and regulatory considerations.
  page_keywords: >-
    chemical risk assessment, non-cancer risk assessment, cancer risk assessment, hazard identification, exposure assessment, dose-response assessment, risk characterization, health effects, carcinogens, regulatory focus
author: QuickTakes
question: >-
    How do non-cancer and cancer risk assessments differ in chemical risk assessment?
answer: >-
    In chemical risk assessment, non-cancer and cancer risk assessments differ primarily in their methodologies and the nature of the health effects they evaluate. Both types of assessments follow a four-step process: hazard identification, exposure assessment, dose-response assessment, and risk characterization. However, the specifics of these steps can vary significantly between non-cancer and cancer assessments.\n\n### Non-Cancer Risk Assessment\n1. **Hazard Identification**: This step determines whether a chemical poses a non-cancer hazard, focusing on various adverse health effects such as respiratory issues, reproductive toxicity, or neurotoxicity.\n2. **Exposure Assessment**: This evaluates the extent and duration of exposure to the chemical, considering different exposure pathways (e.g., inhalation, ingestion, dermal contact).\n3. **Dose-Response Assessment**: This examines the relationship between the dose of the chemical and the severity of the non-cancer health effects. It often involves identifying a reference dose (RfD), which is the maximum acceptable daily exposure level over a lifetime without appreciable risk.\n4. **Risk Characterization**: This integrates the information from the previous steps to estimate the risk of non-cancer health effects, often using hazard quotients to compare estimated exposure levels to the RfD.\n\n### Cancer Risk Assessment\n1. **Hazard Identification**: This step is crucial for identifying potential carcinogens, often requiring extensive data and studies to establish a chemical's cancer-causing potential.\n2. **Exposure Assessment**: Similar to non-cancer assessments, this evaluates exposure levels but may also consider cumulative exposure over time, as cancer risk can be influenced by long-term exposure.\n3. **Dose-Response Assessment**: This step is more complex for cancer assessments, as it involves determining the relationship between dose and the probability of developing cancer. It often uses models to estimate cancer risk at low exposure levels, which may not be directly observed in studies.\n4. **Risk Characterization**: This step provides an estimate of cancer risk, often expressed as a probability (e.g., the likelihood of developing cancer per million people exposed). It may also include a range of uncertainties and assumptions made during the assessment.\n\n### Key Differences\n- **Nature of Health Effects**: Non-cancer assessments focus on a variety of adverse health effects, while cancer assessments specifically target carcinogenic potential.\n- **Complexity and Duration**: Cancer risk assessments are generally more complex, requiring more time and resources (often taking four to six years and costing millions of dollars) due to the need for extensive data and modeling.\n- **Regulatory Focus**: There are fewer chemicals evaluated for cancer risk compared to non-cancer risks, as only those with strong evidence of carcinogenicity are typically subjected to cancer risk assessments.\n\nIn summary, while both non-cancer and cancer risk assessments follow a similar framework, the differences in their focus, complexity, and methodologies reflect the distinct nature of the health effects they aim to evaluate.
subject: Health Studies
file_name: how-do-noncancer-and-cancer-risk-assessments-differ-in-chemical-risk-assessment.md
url: /learn/health-studies/questions/how-do-noncancer-and-cancer-risk-assessments-differ-in-chemical-risk-assessment
score: -1.0
related_article1:
    id: 182619
    title: >-
        What factors are considered in setting chemical exposure limits?
    subject: Health Studies
    url: /learn/health-studies/questions/what-factors-are-considered-in-setting-chemical-exposure-limits
related_article2:
    id: 182603
    title: >-
        What are the main sources and routes of exposure considered in exposure assessment?
    subject: Health Studies
    url: /learn/health-studies/questions/what-are-the-main-sources-and-routes-of-exposure-considered-in-exposure-assessment
related_article3:
    id: 182608
    title: >-
        How are multiple chemicals and pathways considered in risk characterization?
    subject: Health Studies
    url: /learn/health-studies/questions/how-are-multiple-chemicals-and-pathways-considered-in-risk-characterization
---

&nbsp;